Neurological impairments are conditions that affect the nervous system, such as traumatic brain injury, stroke, multiple sclerosis, Alzheimer’s disease, and Parkinson’s disease. They can also include conditions that affect the brain, spine, or peripheral nerves such as epilepsy, autism spectrum disorder, cerebral palsy, amyotrophic lateral sclerosis (ALS), and hydrocephalus. These conditions can lead to physical and cognitive disabilities due to damage to the brain, spinal cord, or nerves. Neurological impairments can affect a person’s ability to think, speak, move, and interact with others. Symptoms may include difficulty in movement, communication, memory, processing, and sensory perception, as well as changes in behavior, mood, and alertness. Treatment for neurological impairments may involve medication, physical or occupational therapy, speech therapy, or psychological counseling. Assistive devices may also be used to improve quality of life. Depending on the severity of the impairment, treatment may focus on symptom management or improving function and cognition. Neurological impairments can also lead to secondary problems such as depression, pain, or fatigue. It is important to recognize and to provide support to those who live with neurological impairments. Providing appropriate facilities and services to address their needs can help enable individuals to live a higher quality of life. Further research in this area is essential to uncover potential treatment options and to provide better treatment and care to individuals living with neurological impairments.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom